Noninvasive positive pressure ventilation in status asthmaticus

Objective: In asthmatic patients with acute respiratory failure (ARF), placing an endotracheal tube is associated with a high rate of complications and results in increased airway resistance. In acute asthma, mask-continuous positive airway pressure (CPAP) decreases airway resistance and the work of breathing (WOE), but does not improve gas exchange. In COPD with ARF, adding intermittent positive pressure ventilation to mask-CPAP results in an additional improvement in WOE and is highly effective in correcting gas exchange abnormalities. In our medical ICU, noninvasive positive pressure ventilation (NPPV) is used as first-line interventional therapy in eligible patients with hypercapnic ARF. We report our experience with NPPV in 17 episodes of asthma and ARF over a 3-year period. Methods: A face mask was secured with head straps, avoiding a tight fit, and connected to a ventilator (PB-7200). Initial ventilatory settings included CPAP at 4+/-2 cm H2O to offset intrinsic positive end-expiratory pressure and pressure support ventilation (PSV) at 14+/-5 cm H2O aiming at a respiratory rate less than 25 breaths/min and an exhaled tidal volume of 7 mL/kg or more. PSV was then adjusted following arterial blood gas results. Results: Mean age was 35.4+/-11.3 years; 10 patients mere female. The mean (+/-SE) for different physiologic values are reported at initiation, less than 2 h, 2 to 6 h, and 12 to 24 h into NPPV. pH was 7.25+/-0.01, 7.32+/-0.02 (p=0.0012), 7.36+/-0.02 (p<0.0001), and 7.38+/-0.02; PaCO2 was 65+/-2, 52+/-3 (p=0.002), 45+/-3 (p<0.0001), and 45+/-4; PaO2 fraction of inspired oxygen was 315+/-41, 403+/-47, 367+/-47, and 472+/-67 (p=0.06); and respiratory rate was: 29.1+/-1, 22+/-1 (p<0.0001), 20+/-1, and 17+/-1. NPPV was well tolerated, and only two patients required sedation. Initial delivered minute ventilation was 16+/-4 L/min. The mean (+/-SD) peak inspiratory pressure to ventilate in the NPPV-treated patients was 18+/-5 cm H2O and always less than 25 cm H2O. There was no complication or problem with expectorating of secretions. Oral intake (liquid diet) was preserved. Two patients required intubation (35 min and 89 h into NPPV) for worsening PaCO2. Duration of NPPV was 16+/-21 h. All patients survived. Length of hospital stay was 5+/-4 days. Conclusions: In asthmatic patients with ARF, NPPV via a face mask appears highly effective in correcting gas exchange abnormalities using a low inspiratory pressure (<25 cm H2O). A randomized study is in progress to assess fully the role of NPPV in status asthmaticus.